<doc>
  <docmeta id="113s2722is">
    <bill congress="113" type="s" number="2722" version="is"/>
    <revision size="7295" annotations="0" status="complete" id="6" commit-time="2014-08-20T21:57:54Z" committer="mbohmer" doc="113s2722is/6.xml">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <bill bill-stage="Introduced-in-Senate" dms-id="A1" public-private="public">
	<metadata>
<dublinCore>
<dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">113 S2722 IS: Protecting Our Infants Act of 2014</dc:title>
<dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">U.S. Senate</dc:publisher>
<dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2014-07-31</dc:date>
<dc:format xmlns:dc="http://purl.org/dc/elements/1.1/">text/xml</dc:format>
<dc:language xmlns:dc="http://purl.org/dc/elements/1.1/">EN</dc:language>
<dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/">Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">II</distribution-code>
		<congress>113th CONGRESS</congress>
    <session>2d Session</session>
		<legis-num>S. 2722</legis-num>
		<current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
		<action>
			<action-date date="20140731">July 31, 2014</action-date>
			<action-desc>
        <sponsor name-id="S174">Mr. McConnell</sponsor> introduced the following bill; which was read twice and referred to the <committee-name committee-id="SSHR00">Committee on Health, Education, Labor, and Pensions</committee-name>
      </action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To facilitate identification and dissemination of evidence-informed recommendations for
			 addressing maternal addiction and neonatal abstinence syndrome and to
			 provide for studies with respect to neonatal abstinence syndrome. </official-title>
	</form>
	<legis-body>
		<section id="S1" section-type="section-one">
      <enum>1.</enum>
      <header>Short title</header>
			<text display-inline="no-display-inline">This Act may be cited as the
		  <quote>
          <short-title>
            <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Protecting Our Infants Act of 2014" proposed="true">Protecting Our Infants Act of 2014</cato:entity-ref>
          </short-title>
        </quote>.</text>
		</section>
    <section id="id737CDE638DCB4FFE884868D8C0428E52">
      <enum>2.</enum>
      <header>Evidence-informed recommendations with respect to maternal addiction and neonatal abstinence
			 syndrome</header>
      <subsection id="id2F44C0465B1B4D6498C23DE2233E95AC">
        <enum>(a)</enum>
        <header>In general</header>
        <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary of Health and Human Services</cato:entity-ref> (referred to in this section as the <quote>Secretary</quote>) shall coordinate and facilitate the—</text>
        <paragraph id="id40c6311627624848b5d62333edec5b31">
          <enum>(1)</enum>
          <text>identification and compilation of evidence-informed recommendations for physicians, nurses, and
			 hospital facilities with respect to neonatal abstinence syndrome; and</text>
        </paragraph>
        <paragraph id="id2913711b03b149a7b7299f095246b55c">
          <enum>(2)</enum>
          <text>identification of any gaps, as appropriate, in such evidence-informed recommendations that may
			 require additional research or analysis with respect to—</text>
          <subparagraph id="id51a9599ebe86484d8a1e3f576e7a947f">
            <enum>(A)</enum>
            <text>screening and intervention for maternal substance abuse, including the misuse or abuse of
			 prescription drugs in women of childbearing age and pregnant women;</text>
          </subparagraph>
          <subparagraph id="id64a8ddcdeb8748daae44fa5a42087709">
            <enum>(B)</enum>
            <text>treatment for pregnant and post­par­tum women with a substance use disorder, including the misuse
			 or
			 abuse of prescription drugs;</text>
          </subparagraph>
          <subparagraph id="id246c969053434cc8b8942a72c0fee1ad">
            <enum>(C)</enum>
            <text>screening of infants for neonatal abstinence syndrome and for the risk of developing neonatal
			 abstinence syndrome;</text>
          </subparagraph>
          <subparagraph id="idb7636aad49fe4520989b6937d7c2483a">
            <enum>(D)</enum>
            <text>treatment for infants with neonatal abstinence syndrome, including evidence-informed
			 recommendations surrounding evaluation and treatment with pharmacological
			 and non-pharmacological interventions; and</text>
          </subparagraph>
          <subparagraph id="id8e013c2fb5874ac293de6c4a7f99b0bf">
            <enum>(E)</enum>
            <text>ongoing treatment, services, and supports for postpartum women with a substance use disorder,
			 including misuse or abuse of prescription drugs, and infants and children
			 with neonatal abstinence syndrome.</text>
          </subparagraph>
        </paragraph>
      </subsection>
      <subsection id="id32da2f0e0945436ea76e1325d190e45c">
        <enum>(b)</enum>
        <header>Input</header>
        <text>In carrying out subsection (a), the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall consider input from stakeholders, such as
			 health professionals, public health officials, and law enforcement.</text>
      </subsection>
      <subsection id="id3f9d0e4782ff493e9cda4c26a0eeb74a">
        <enum>(c)</enum>
        <header>Dissemination of information</header>
        <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall disseminate to appropriate stakeholders in States and local communities the
			 evidence-informed recommendations identified under subsection (a).</text>
      </subsection>
      <subsection id="id00c48777771042f8b3c9de74162dcb30">
        <enum>(d)</enum>
        <header>Addressing Research Needs for Maternal Addiction and Neonatal Abstinence Syndrome</header>
        <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall conduct a study to evaluate—</text>
        <paragraph id="idF774EDFF5665466EAF2805D1C1A3C622">
          <enum>(1)</enum>
          <text>factors related to the increased prevalence of maternal opiate misuse and abuse;</text>
        </paragraph>
        <paragraph id="idC9F019CF578F424E94F3840692BC6EBD">
          <enum>(2)</enum>
          <text>factors related to maternal misuse and abuse of opiates, including—</text>
          <subparagraph id="idB1D76E0042074DAE81A45BF3DDA27722">
            <enum>(A)</enum>
            <text>barriers to identifying and treating maternal misuse and abuse of opiates; and</text>
          </subparagraph>
          <subparagraph id="idED2DC55469974687AD9E67C1E26E29F3">
            <enum>(B)</enum>
            <text>the most effective prevention and treatment strategies for pregnant women and other women of
			 childbearing age who are at risk for or dependent on opiates; and</text>
          </subparagraph>
        </paragraph>
        <paragraph id="id8287DB8B395346BAB2CA5FDE3EA7F106">
          <enum>(3)</enum>
          <text>factors related to neonatal abstinence syndrome, including—</text>
          <subparagraph id="idAB76CB7F7D6B497C9B264DD0A821090C">
            <enum>(A)</enum>
            <text>epidemiological studies concerning neonatal abstinence syndrome;</text>
          </subparagraph>
          <subparagraph id="id78E9D1435D1E45558917248F6FCE02D0">
            <enum>(B)</enum>
            <text>the most effective methods to diagnose and treat neonatal abstinence syndrome; and</text>
          </subparagraph>
          <subparagraph id="idBF7691DF980B4CDC8019EAC4E58477C4">
            <enum>(C)</enum>
            <text>the long-term effects of neonatal abstinence syndrome and the need for a longer-term study on
			 infants and children at risk for developing neonatal abstinence syndrome
			 or diagnosed with neonatal abstinence syndrome.</text>
          </subparagraph>
        </paragraph>
      </subsection>
      <subsection id="idD1C7E5D95FDB470DB74F4C55360095EA">
        <enum>(e)</enum>
        <header>Report</header>
        <text>Not later than 1 year after the date of enactment of this Act, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall provide to the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="SSHR00" entity-type="committee">Committee on Health, Education, Labor, and Pensions of the
			 Senate</cato:entity-ref> and the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="HIF00" entity-type="committee">Committee on Energy and Commerce of the House of
			 Representatives</cato:entity-ref> the findings from the study under subsection (d) and a
			 report that identifies the gaps in evidence-informed
			 recommendations that require additional research or analysis, and priority
			 areas for additional research.</text>
      </subsection>
    </section>
    <section id="id8debdcb3e59349e1b75ff26cc1809e69">
      <enum>3.</enum>
      <header>Improving data on neonatal abstinence syndrome</header>
      <text display-inline="no-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary of Health and Human Services</cato:entity-ref>, acting through the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7523" entity-type="federal-body">Director of the Centers for Disease
			 Control and Prevention</cato:entity-ref>, shall
			 provide technical assistance to States to improve the availability and
			 quality of data collection and surveillance activities regarding neonatal
			 abstinence syndrome, including—</text>
      <paragraph id="id69ed3b809dbf4f258efa922215df46a0">
        <enum>(1)</enum>
        <text>incidence and prevalence of neonatal abstinence syndrome;</text>
      </paragraph>
      <paragraph id="id3575fc0f0d034029a402674dfc64cbd2">
        <enum>(2)</enum>
        <text>the identification of causes for neonatal abstinence syndrome, including new and emerging trends;
			 and</text>
      </paragraph>
      <paragraph id="idabb20d030a274ada98048befa8cc3c2c">
        <enum>(3)</enum>
        <text>the identification of demographics and other relevant information associated with neonatal
			 abstinence syndrome.</text>
      </paragraph>
    </section>
    <section id="idf5fab6d49a92406992111bb0e9ce9533">
      <enum>4.</enum>
      <header>Pain management alternatives</header>
      <text display-inline="no-display-inline">It is the sense of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0001">Congress</cato:entity-ref> that the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7529" entity-type="federal-body">Director of the National Institutes of Health</cato:entity-ref> should continue
			 research with respect to pain management, including for women of
			 childbearing age.</text>
    </section>
    <section id="ide752710d80744be38e570b763879d527">
      <enum>5.</enum>
      <header>GAO study</header>
      <text display-inline="no-display-inline">Not later than 1 year after the date of enactment of this Act, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="0500" entity-type="federal-body">Comptroller General of the
			 United States</cato:entity-ref> shall conduct a study evaluating—</text>
      <paragraph id="id631de76d5c86427ca74520a5b1954173">
        <enum>(1)</enum>
        <text>the availability and effectiveness of federally facilitated substance abuse treatment programs for
			 pregnant women and their children;</text>
      </paragraph>
      <paragraph id="id962c28bf09164737811265edc4dfbada">
        <enum>(2)</enum>
        <text>the availability and effectiveness of Federal programs that encourage State adoption and
			 implementation of programs to ensure—</text>
        <subparagraph id="idf28442c966684b32a2d6559d10145298">
          <enum>(A)</enum>
          <text>the safety and health of mothers who have a substance use disorder; and</text>
        </subparagraph>
        <subparagraph id="id45a46b8a827b4956bf85853b5b82aa2f">
          <enum>(B)</enum>
          <text>the safety and health of children with neonatal abstinence syndrome;</text>
        </subparagraph>
      </paragraph>
      <paragraph id="idaa326058d12c465fb9c6771dd50c65a6">
        <enum>(3)</enum>
        <text>the effectiveness of Federal data systems and surveillance programs used to monitor or track drug
			 utilization and resulting trends, including whether information on
			 neonatal abstinence syndrome is incorporated into such data systems; and</text>
      </paragraph>
      <paragraph id="id64419d65f6c242659222d17c055ddf35">
        <enum>(4)</enum>
        <text>the identification of the use of all discretionary funds to address maternal substance abuse,
			 including the misuse and abuse of prescription drugs.</text>
			</paragraph>
    </section>
  </legis-body>
</bill>
</doc>